Parkin Binds to α/β Tubulin and Increases their Ubiquitination and Degradation
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
In addition to inhibiting the mitochondrial respiratory chain, toxins known to cause Parkinson9s disease (PD), such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and rotenone, also strongly depolymerize microtubules and increase tubulin degradation. Microtubules are polymers of tubulin α/β heterodimers, whose correct folding requires coordinated actions of cellular chaperonins and cofactors. Misfolded tubulin monomers are highly toxic and quickly degraded through a hitherto unknown mechanism. Here we report that parkin, a protein–ubiquitin E3 ligase linked to PD, was tightly bound to microtubules in taxol-mediated microtubule coassembly assays. In lysates from the rat brain or transfected human embryonic kidney (HEK) 293 cells, α-tubulin and β-tubulin were strongly coimmunoprecipitated with parkin at 4°C in the presence of colchicine, a condition in which tubulin exits as α/β heterodimers. At the subcellular level, parkin exhibited punctate immunostaining along microtubules in rat brain sections, cultured primary neurons, glial cells, and cell lines. This pattern of subcellular localization was abolished in cells treated with the microtubule-depolymerizing drug colchicine. The binding between parkin and tubulin apparently led to increased ubiquitination and accelerated degradation of α- and β-tubulins in HEK293 cells. Similarly ubiquitinated tubulins were also observed in rat brain lysates. Furthermore, parkin mutants found in PD patients did not ubiquitinate or degrade either tubulin. Taken together, our results show that parkin is a novel tubulin-binding protein, as well as a microtubule-associated protein. Its ability to enhance the ubiquitination and degradation of misfolded tubulins may play a significant role in protecting neurons from toxins that cause PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 2×
“JP) (Kitada et al., 1998) has been found to be a protein– ubiquitin”
BackgroundChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 1×
“…(Cleveland, 1989), the cellular mechanism for the degradation of tubulin in response to these neurotoxins may play a role in PD. Parkin, a gene linked to autosomal recessive juvenile PD (AR- JP) (Kitada et al., 1998) has been found to be a protein– ubiquitin E3 ligase (Shimura et al., 2000).”
BackgroundShimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053 · cited 1×
“Although previous studies have identified several substrates of parkin in the cell (Zhang et al., 2000; Chung et al., 2001; Imai et al., 2001; Shimura et al., 2001), it is clear that parkin may have additional substrates that contribute to the degeneration of nigral DA neurons.”
BackgroundImai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., & Takahashi, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00407-x · Cited by 1,050
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982 · cited 2×
“Many of the mutations appear to be clustered in the ubiquitin-like domain and the RING (Really Interesting New Gene) finger domains (Giasson and Lee, 2001), suggesting that the E3 ligase activity of parkin is crucial for PD. Although previous studies have identified several substrates of parkin in the cell ( Zhang et…”
BackgroundChung, K. K. K., Zhang, Y., Lim, K. L., Tanaka, Y., Huang, H., Gao, J., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1144 · Cited by 750 · cited 1×
“Although previous studies have identified several substrates of parkin in the cell (Zhang et al., 2000; Chung et al., 2001; Imai et al., 2001; Shimura et al., 2001), it is clear that parkin may have additional substrates that contribute to the degeneration of nigral DA neurons.”
BackgroundLowe, J., Blanchard, A., Morrell, K., Lennox, G., Reynolds, L., Billett, M., Landon, M., & Mayer, R. J. (1988) · The Journal of Pathology · doi:10.1002/path.1711550105 · Cited by 539
Lactacystin, Proteasome Function, and Cell Fate
Fenteany, G., & Schreiber, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8545 · Cited by 410
PACHTER, J. (1987) · Cell · doi:10.1016/0092-8674(87)90155-3 · Cited by 206
Fallon, L., Moreau, F., Croft, B. G., Labib, N., Gu, W.-J., & Fon, E. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109806200 · Cited by 190
Dominant effects of tubulin overexpression in Saccharomyces cerevisiae.
Burke, D., Gasdaska, P., & Hartwell, L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1049 · Cited by 189
Parkin and the Molecular Pathways of Parkinson's Disease
Giasson, B. I., & Lee, V. M.-Y. (2001) · Neuron · doi:10.1016/s0896-6273(01)00439-1 · Cited by 159
Filaments of Lewy bodies contain insoluble cytoskeletal elements.
Galloway, P. G., Mulvihill, P., & Perry, G. L. (1992) · PubMed Central · Cited by 150
Wang, D., Moriggl, R., Stravopodis, D. J., Carpino, N., Marine, J., Teglund, S., Feng, J., & Ihle, J. N. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.392 · Cited by 139
Self-citationRotenone inhibition of tubulin self-assembly
Marshall, L. E., & Himes, R. H. (1978) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(78)90315-x · Cited by 134
ASSOCIATION BETWEEN EARLY-ONSET PARKINSON'S DISEASE AND MUTATIONS IN THE PARKIN GENE
Ücking, B. L., Onifati, V. I. B., Aughan, J. E. V., et al. (2000) · Cited by 129
Microtubules and axonal growth
Baas, P. W. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80148-2 · Cited by 128
Rotenone inhibition of spindle microtubule assembly in mammalian cells
Brinkley, B. R., Barham, S. S., BARRANCO, S. C., & Fuller, G. M. (1974) · Experimental Cell Research · doi:10.1016/0014-4827(74)90210-9 · Cited by 115
[11] Purification of brain microtubules and microtubule-associated protein 1 using taxol
Vallee, R. B. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)34079-5 · Cited by 68
Microtubule Transport in the Axon
Baas, P. W. (2002) · International review of cytology · doi:10.1016/s0074-7696(01)12003-6 · Cited by 54
Intermediate filament-ubiquitin diseases: implications for cell sanitization.
Mayer, R. J., Lowe, J. S., Lennox, G. G., Landon, M., MacLennan, K. A., & DOHERTY, F. J. (1989) · PubMed · Cited by 28
Cited by
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
Pandey, U. B., & Nichols, C. D. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003293 · Cited by 1,136
The tubulin code and its role in controlling microtubule properties and functions
Janke, C., & Magiera, M. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0214-3 · Cited by 956
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913
Toxin-induced models of Parkinson’s disease
Bové, J., Prou, D., Perier, C., & Przedborski, S. (2005) · NeuroRX · doi:10.1602/neurorx.2.3.484 · Cited by 739
“Interestingly, a protein implicated in some familial forms of PD, parkin, appears to bind to tubulin, thereby enhancing the ubiquitination and degradation of misfolded tubulins, an effect that is lacking with the PD-linked parkin mutants.(103)”
Background
Metadata
- Authors
- Ren, Y., Zhao, J., & Feng, J.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2003-04-15
- Volume
- 23
- Issue
- 8
- Pages
- 3316-3324
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W4297062289
- Cited by
- 265
- References
- 24
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.